Keyphrases
Liver
100%
Phase II Trial
100%
Chemoembolization
100%
Metastatic Colorectal Cancer (mCRC)
100%
Systemic Treatment
33%
Treatment Modalities
33%
Colorectal Carcinoma
33%
Carcinoma Metastasis
33%
Hepatic Artery Chemoembolization
33%
Metastasis
16%
Anemia
16%
Disease Progression
16%
Thrombocytopenia
16%
Median Survival
16%
Moderate to Severe
16%
Clinical Benefit
16%
Cisplatin
16%
Neoplastic Lesions
16%
Bovine Collagen
16%
Nausea
16%
Fever
16%
Initial Diagnosis
16%
Entry Criteria
16%
Radiological Response
16%
Vomiting
16%
High Response Rate
16%
Repeated Treatment
16%
Leukocytosis
16%
Lethargy
16%
Hematotoxicity
16%
Mitomycin C
16%
Right Upper Quadrant
16%
Collagen-based Materials
16%
Carcinoembryonic Antigen Levels
16%
Post-embolization Syndrome
16%
Doxorubin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Phase II Trials
100%
Colorectal Carcinoma
100%
Systemic Treatment
66%
Cisplatin
33%
Mitomycin
33%
Syndrome
33%
Nausea and Vomiting
33%
Anemia
33%
Thrombocytopenia
33%
Carcinoembryonic Antigen
33%
Leukocytosis
33%
Diseases
33%
Medicine and Dentistry
Phase II Trials
100%
Transcatheter Arterial Chemoembolization
100%
Colorectal Carcinoma
100%
Metastatic Carcinoma
50%
Systemic Therapy
33%
Hepatic Artery Chemoembolization
33%
Leukocytosis
16%
Anemia
16%
Thrombocytopenia
16%
Nausea and Vomiting
16%
Cisplatin
16%
Carcinoembryonic Antigen
16%
Mitomycin
16%
Diseases
16%